Industry Overview : Global Targeted RNA Sequencing Market Research Report 2018 – Illumina, BGI, Eurofins
This report studies the global Targeted RNA Sequencing market status and forecast, categorizes the global Targeted RNA Sequencing market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.
Fill the form to gain deeper insights on this market @ https://www.qyresearchreports.com/sample/sample.php?rep_id=1854654&type=S
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.
Market competition is not intense. Thermo Fisher, Illumina, RocheHoldings, BGI, Eurofins, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global Targeted RNA Sequencing market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.
The major manufacturers covered in this report
Thermo Fisher
Illumina
RocheHoldings
BGI
Eurofins
LabCorp
Berry Genomics
Macrogen
GENEWIZ
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
North America
Europe
China
Japan
Southeast Asia
India
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
enrichment approaches
amplicon-based approaches
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
ResearchInstitutes
Hospitals&Clinics
BiotechnologyCompany
Diagnostic Lab
Obtain Report Details @ https://www.qyresearchreports.com/report/global-targeted-rna-sequencing-market-research-report-2018.htm
The study objectives of this report are:
To analyze and study the global Targeted RNA Sequencing sales, value, status (2013-2017) and forecast (2018-2025).
Focuses on the key Targeted RNA Sequencing manufacturers, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Targeted RNA Sequencing are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Targeted RNA Sequencing Manufacturers
Targeted RNA Sequencing Distributors/Traders/Wholesalers
Targeted RNA Sequencing Subcomponent Manufacturers
Industry Association
Downstream Vendors
About Us:
QYResearchReports.com delivers the latest strategic market intelligence to build a successful business footprint in China. Our syndicated and customized research reports provide companies with vital background information of the market and in-depth analysis on the Chinese trade and investment framework, which directly affects their business operations. Reports from QYResearchReports.com feature valuable recommendations on how to navigate in the extremely unpredictable yet highly attractive Chinese market.
Contact Us:
1820 Avenue
M Suite #1047
Brooklyn, NY 11230
United States
Toll Free: 866-997-4948 (USA-CANADA)
Tel: +1-518-621-2074
Email: sales@qyresearchreports.com
Blog – http://qyresearch-group.blogspot.com/
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.
Fill the form to gain deeper insights on this market @ https://www.qyresearchreports.com/sample/sample.php?rep_id=1854654&type=S
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.
Market competition is not intense. Thermo Fisher, Illumina, RocheHoldings, BGI, Eurofins, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global Targeted RNA Sequencing market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.
The major manufacturers covered in this report
Thermo Fisher
Illumina
RocheHoldings
BGI
Eurofins
LabCorp
Berry Genomics
Macrogen
GENEWIZ
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
North America
Europe
China
Japan
Southeast Asia
India
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
enrichment approaches
amplicon-based approaches
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
ResearchInstitutes
Hospitals&Clinics
BiotechnologyCompany
Diagnostic Lab
Obtain Report Details @ https://www.qyresearchreports.com/report/global-targeted-rna-sequencing-market-research-report-2018.htm
The study objectives of this report are:
To analyze and study the global Targeted RNA Sequencing sales, value, status (2013-2017) and forecast (2018-2025).
Focuses on the key Targeted RNA Sequencing manufacturers, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Targeted RNA Sequencing are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Targeted RNA Sequencing Manufacturers
Targeted RNA Sequencing Distributors/Traders/Wholesalers
Targeted RNA Sequencing Subcomponent Manufacturers
Industry Association
Downstream Vendors
About Us:
QYResearchReports.com delivers the latest strategic market intelligence to build a successful business footprint in China. Our syndicated and customized research reports provide companies with vital background information of the market and in-depth analysis on the Chinese trade and investment framework, which directly affects their business operations. Reports from QYResearchReports.com feature valuable recommendations on how to navigate in the extremely unpredictable yet highly attractive Chinese market.
Contact Us:
1820 Avenue
M Suite #1047
Brooklyn, NY 11230
United States
Toll Free: 866-997-4948 (USA-CANADA)
Tel: +1-518-621-2074
Email: sales@qyresearchreports.com
Blog – http://qyresearch-group.blogspot.com/